CLINICAL_TRIALS
trial_result
· 2011-05-09
Clinical Trial Update: Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib [Phase 2]
Summary
A Phase 2 trial evaluated adjuvant bevacizumab plus erlotinib for prostate cancer; results were posted after completion in May 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Translational Oncology Research International | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-09